Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft.

Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft. Clin Cancer Res. 2000 Oct; 6(10):4154-7.

View in: PubMed

subject areas

Animals
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Antineoplastic Combined Chemotherapy Protocols
Camptothecin
Dacarbazine
Female
Humans
Male
Mice
Mice, Inbred BALB C
Neoplasm Transplantation
Nervous System Neoplasms
Time Factors
Tumor Cells, Cultured

authors with profiles

Mary Eileen Dolan